These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 1802990)
1. Inhibitory effect of cannabidiol hydroxy-quinone, an oxidative product of cannabidiol, on the hepatic microsomal drug-metabolizing enzymes of mice. Watanabe K; Usami N; Yamamoto I; Yoshimura H J Pharmacobiodyn; 1991 Jul; 14(7):421-7. PubMed ID: 1802990 [TBL] [Abstract][Full Text] [Related]
2. Generation of reactive oxygen species during mouse hepatic microsomal metabolism of cannabidiol and cannabidiol hydroxy-quinone. Usami N; Yamamoto I; Watanabe K Life Sci; 2008 Nov; 83(21-22):717-24. PubMed ID: 18929579 [TBL] [Abstract][Full Text] [Related]
3. Self-catalyzed inactivation of cytochrome P-450 during microsomal metabolism of cannabidiol. Watanabe K; Arai M; Narimatsu S; Yamamoto I; Yoshimura H Biochem Pharmacol; 1987 Oct; 36(20):3371-7. PubMed ID: 3675599 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of hepatic microsomal cytochrome P450 by cannabidiol in adult male rats. Narimatsu S; Watanabe K; Matsunaga T; Yamamoto I; Imaoka S; Funae Y; Yoshimura H Chem Pharm Bull (Tokyo); 1990 May; 38(5):1365-8. PubMed ID: 2393963 [TBL] [Abstract][Full Text] [Related]
6. Identification of cannabielsoin, a new metabolite of cannabidiol formed by guinea-pig hepatic microsomal enzymes, and its pharmacological activity in mice. Yamamoto I; Gohda H; Narimatsu S; Yoshimura H J Pharmacobiodyn; 1988 Dec; 11(12):833-8. PubMed ID: 3254981 [TBL] [Abstract][Full Text] [Related]
7. Mechanism for inhibitory effect of cannabidiol on microsomal testosterone oxidation in male rat liver. Narimatsu S; Watanabe K; Yamamoto I; Yoshimura H Drug Metab Dispos; 1988; 16(6):880-9. PubMed ID: 2907469 [TBL] [Abstract][Full Text] [Related]
8. Formation of carbon monoxide during mouse hepatic microsomal oxidative metabolism of cannabidiol; identification and determination. Usami N; Tateoka Y; Watanabe K; Yamamoto I; Yoshimura H Biol Pharm Bull; 1995 Apr; 18(4):529-35. PubMed ID: 7655421 [TBL] [Abstract][Full Text] [Related]
9. Effect of cannabidiol on cytochrome P-450 isozymes. Bornheim LM; Correia MA Biochem Pharmacol; 1989 Sep; 38(17):2789-94. PubMed ID: 2550010 [TBL] [Abstract][Full Text] [Related]
10. Characterization of cannabidiol-mediated cytochrome P450 inactivation. Bornheim LM; Everhart ET; Li J; Correia MA Biochem Pharmacol; 1993 Mar; 45(6):1323-31. PubMed ID: 8466552 [TBL] [Abstract][Full Text] [Related]
11. Effects of two cannabinoids on hepatic microsomal cytochrome P-450. Watanabe K; Hamajima K; Narimatsu S; Yamamoto I; Yoshimura H J Pharmacobiodyn; 1986 Jan; 9(1):39-45. PubMed ID: 3012058 [TBL] [Abstract][Full Text] [Related]
12. Effect of repeated administration of 11-hydroxy-delta 8-tetrahydrocannabinol, an active metabolite of delta 8-tetrahydrocannabinol, on the hepatic microsomal drug-metabolizing enzyme system of mice. Watanabe K; Arai M; Narimatsu S; Yamamoto I; Yoshimura H Biochem Pharmacol; 1986 Jun; 35(11):1861-5. PubMed ID: 3013200 [TBL] [Abstract][Full Text] [Related]
13. Cannabidiol is a potent inhibitor of the catalytic activity of cytochrome P450 2C19. Jiang R; Yamaori S; Okamoto Y; Yamamoto I; Watanabe K Drug Metab Pharmacokinet; 2013; 28(4):332-8. PubMed ID: 23318708 [TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo interactions of delta 8-tetra-hydrocannabinol and its metabolites with hepatic microsomal drug metabolizing enzyme systems of mice. Watanabe K; Yamamoto I; Oguri K; Yoshimura H J Pharmacobiodyn; 1981 Aug; 4(8):604-11. PubMed ID: 6271944 [TBL] [Abstract][Full Text] [Related]
15. Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes. Jiang R; Yamaori S; Takeda S; Yamamoto I; Watanabe K Life Sci; 2011 Aug; 89(5-6):165-70. PubMed ID: 21704641 [TBL] [Abstract][Full Text] [Related]
16. Development of tolerance to the prolongation of hexobarbitone sleeping time caused by cannabidiol. Borys HK; Ingall GB; Karler R Br J Pharmacol; 1979 Sep; 67(1):93-101. PubMed ID: 497524 [TBL] [Abstract][Full Text] [Related]
17. [Sex difference in the effects of delta 9-tetrahydrocannabinol and cannabidiol on pentobarbital-induced sleeping time and hepatic microsomal drug metabolizing enzyme systems in mice]. Hamajima K; Watanabe K; Narimatsu S; Tateoka Y; Yamamoto I; Yoshimura H Yakugaku Zasshi; 1983 Dec; 103(12):1289-97. PubMed ID: 6330340 [No Abstract] [Full Text] [Related]
18. Mechanism of biological formation of cannabielsoin from cannabidiol in the guinea-pig, mouse, rat and rabbit. Yamamoto I; Gohda H; Narimatsu S; Yoshimura H J Pharmacobiodyn; 1989 Aug; 12(8):488-94. PubMed ID: 2614640 [TBL] [Abstract][Full Text] [Related]
19. Cannabidiol, a major phytocannabinoid, as a potent atypical inhibitor for CYP2D6. Yamaori S; Okamoto Y; Yamamoto I; Watanabe K Drug Metab Dispos; 2011 Nov; 39(11):2049-56. PubMed ID: 21821735 [TBL] [Abstract][Full Text] [Related]
20. Role of 3,4-dichlorophenyl methyl sulfone, a metabolite of o-dichlorobenzene, in the changes in hepatic microsomal drug-metabolizing enzymes caused by o-dichlorobenzene administration in rats. Kato Y; Kimura R Toxicol Appl Pharmacol; 1997 Aug; 145(2):277-84. PubMed ID: 9266800 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]